ANTHEM BIOSCIENCES
Back to Balance Sheet
|
ANTHEM BIOSCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-27 Cr | ₹-18 Cr | ₹-41 Cr | ₹-25 Cr | ₹-16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ANTHEM BIOSCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-27 Cr |
| Mar2025 | ₹-18 Cr |
| Mar2024 | ₹-41 Cr |
| Mar2023 | ₹-25 Cr |
| Mar2022 | ₹-16 Cr |
How is Deferred Tax Assets / Liabilities of ANTHEM BIOSCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-27 Cr | Negative | |
| Mar2025 | ₹-18 Cr | Negative | |
| Mar2024 | ₹-41 Cr | Negative | |
| Mar2023 | ₹-25 Cr | Negative | |
| Mar2022 | ₹-16 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ANTHEM BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANTHEM BIOSCIENCES | ₹44,170.6 Cr | 0.7% | 1.2% | 8.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
ANTHEM BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANTHEM BIOSCIENCES | 0.7% |
1.2% |
8.2% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses